Effect of Ursodeoxycholic Acid or Ursodeoxycholic Acid Combined with Losartan for Treatment of Non-Alcoholic Steatohepatitis

Trial Profile

Effect of Ursodeoxycholic Acid or Ursodeoxycholic Acid Combined with Losartan for Treatment of Non-Alcoholic Steatohepatitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 May 2014

At a glance

  • Drugs Losartan (Primary) ; Ursodeoxycholic acid
  • Indications Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2014 New trial record
    • 11 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top